Saval Corporation is a Chilean pharmaceutical company headquartered in Santiago, Chile. Founded in 1942, Saval has become one of the leading pharmaceutical companies in Chile, with a strong focus on central nervous system medications and a growing presence across South America[@saval2024].
Saval maintains a robust CNS portfolio with approximately 150+ pharmaceutical products across multiple therapeutic categories. The company's neuroscience division has grown significantly over the past decade, driven by increasing demand for neurodegenerative disease treatments in Latin America[@saval2024].
Product Portfolio Details
Alzheimer's Disease Treatments
Saval provides essential Alzheimer's disease treatments including donepezil (generic and branded formulations), rivastigmine in both capsule and transdermal patch forms, memantine tablets, and galantamine. The company has focused on ensuring broad access to these medications across Chile and neighboring markets, recognizing the growing burden of Alzheimer's disease in the region. ...
Overview
Saval Corporation is a Chilean pharmaceutical company headquartered in Santiago, Chile. Founded in 1942, Saval has become one of the leading pharmaceutical companies in Chile, with a strong focus on central nervous system medications and a growing presence across South America[@saval2024].
Saval maintains a robust CNS portfolio with approximately 150+ pharmaceutical products across multiple therapeutic categories. The company's neuroscience division has grown significantly over the past decade, driven by increasing demand for neurodegenerative disease treatments in Latin America[@saval2024].
Product Portfolio Details
Alzheimer's Disease Treatments
Saval provides essential Alzheimer's disease treatments including donepezil (generic and branded formulations), rivastigmine in both capsule and transdermal patch forms, memantine tablets, and galantamine. The company has focused on ensuring broad access to these medications across Chile and neighboring markets, recognizing the growing burden of Alzheimer's disease in the region.
Parkinson's Disease Medications
The company offers comprehensive Parkinson's disease medications including standard and controlled-release [levodopa](/therapeutics/levodopa)/carbidopa formulations, pramipexole as a dopamine agonist, rotigotine transdermal patches for continuous dopaminergic stimulation, and monoamine oxidase-B inhibitors including selegiline and rasagiline. This comprehensive portfolio allows Saval to address various stages of Parkinson's disease management.
Related Neurological Conditions
Beyond AD and PD, Saval addresses related neurological conditions including epilepsy medications (valproate, carbamazepine, levetiracetam), neuropathic pain treatments (pregabalin, gabapentin), and mood stabilizers for dementia-related behavioral symptoms. This broader neurological focus positions Saval as a key provider for CNS disorders in the Latin American market.
Research and Development
Saval maintains an active research and development program focused on neuroscience:
R&D Center in Santiago: Dedicated CNS drug development facility employing approximately 50 researchers
University Partnerships: Collaborations with University of Chile and Pontifical Catholic University for basic neuroscience research
Bioequivalence Studies: Extensive generic CNS medication development ensuring therapeutic equivalence to branded equivalents
Clinical Trials: Participation in international clinical trials for novel neurodegenerative disease therapies
The company has invested significantly in developing generic versions of recently off-patent CNS medications, improving accessibility for Chilean and regional patients[@chilebiotech].
Regional Presence
Saval distributes through a comprehensive regional network:
Chile: Direct presence as home market leader with nationwide distribution
Peru: Subsidiary with dedicated salesforce covering the Peruvian market
Bolivia: Distribution partnership for essential CNS medications
Ecuador: Distribution agreement covering the Ecuadorian market
Export Markets: Occasional exports to other South American markets as needed
This regional presence makes Saval one of the most important CNS pharmaceutical providers in the Spanish-speaking Andean region.
Distribution Infrastructure
| Country | Model | Facilities | |---------|-------|------------| | Chile | Direct | Santiago HQ, 3 warehouses | | Peru | Subsidiary | Lima office, 2 warehouses | | Bolivia | Distribution | La Paz partner | | Ecuador | Distribution | Quito partner |